Results 121 to 130 of about 3,523 (219)

Cost Effectiveness of Letermovir as Cytomegalovirus Prophylaxis in in Allogeneic Hematopoietic Stem Cell Transplant Recipients

, 2018
Jonathan Schelfhout, Yiling Jiang, LaStella Miles, Sanjay Merchant, James E. Graham   +4 more
openalex   +1 more source

CMV-RNAemia as new marker of active viral replication in transplant recipients [PDF]

N
Bonifazi F., Borgatti E. C., Cantiani A., Franceschiello M., Gabrielli L., Giannella M., Gibertoni D., Lanna F., Lazzarotto T., Leone M., Motta V., Pascale R., Pavoni M., Piccirilli G.   +13 more
core   +1 more source

Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study [PDF]

, 2021
Kimitaka Suetsugu, Shota Muraki, Junshiro Fukumoto, Ryosuke Matsukane, Yasuo Mori, Takeshi Hirota, Toshihiro Miyamoto, Nobuaki Egashira, Koichi Akashi, Ichiro Ieiri   +9 more
openalex   +1 more source

2704. Real-world safety and effectiveness of letermovir for preventing cytomegalovirus (CMV) disease in patients undergoing allogenic hematopoietic stem cell transplantation (allo-HSCT): Final results of post-marketing surveillance (PMS) in Japan [PDF]

, 2023
Masaki Fukuda, Junko Hattori, Rika Ohkubo, Asuka Watanabe, Shinichiroh Maekawa   +4 more
openalex   +1 more source

P-2361. Real-World Experience of Letermovir for CMV Prophylaxis in Solid Organ Transplant Recipients [PDF]

Evaristo Varo Pérez, Alexandra Cheezem, Pierina Cabrera-Rios, M Mácek, Ennie Cano, Lilian M. Abbo, Christine Vu   +6 more
openalex   +1 more source

Letermovir use in children after hematopoietic cell transplantation: summary of reported data

, 2023
Tomasz Styczyński, Jagoda Sadlok, Monika Richert-Przygońska, K Czyźewski   +3 more
openalex   +2 more sources

<p>Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review</p>

, 2019
Guy El Helou, Raymund R. Razonable
openalex   +2 more sources

Letermovir Prophylaxis in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant

, 2020
Isabelle T. Nguyen, Joyce J. Johnsrud, Janice M. Brown, Walter Domingo   +3 more
openalex   +1 more source

New Drug: Letermovir for cytomegalovirus prophylaxis [PDF]

, 2019

openalex   +1 more source

Pharmacokinetic analysis driven letermovir dosing in pediatric hematopoietic cell transplantation patients with resistant CMV disease [PDF]

, 2023
Vinita B. Pai, Jessica Tansmore, Eunkyung Song   +2 more
openalex   +1 more source